Sulfuric Acid — predicted protein targets

Known targets — ChEMBL curated mechanism

ADRA1A ADRA1B ADRA1D ADRA2A ADRA2B ADRA2C ADRB1 ADRB2 ADRB3 CALCRL CHRM1 CHRM2 CHRM3 F2R MAOA MAOB MAP2K1 MAP2K2 NTRK1 NTRK2 NTRK3 OPRD1 OPRK1 OPRM1 P2RY12 PKLR SCN10A SCN11A SCN1A SCN2A SCN3A SCN4A SCN5A SCN7A SCN8A SCN9A SLC18A2 SLC6A2 SLC6A3 TLR7 TLR9 TUBA1A TUBA1B TUBA1C TUBA3C TUBA3E TUBA4A TUBB TUBB1 TUBB2A TUBB2B TUBB3 TUBB4A TUBB4B TUBB6 TUBB8 dacA dacB dacC folA ftsI mrcA mrcB mrdA pol rplA rplB rplC rplD rplE rplF rplI rplJ rplK rplL rplM rplN rplO rplP rplQ rplR rplS rplT rplU rplV rplW rplX rplY rpmA rpmB rpmB1 rpmB2 rpmC rpmD rpmE rpmE2 rpmF rpmG rpmG1 rpmG2 rpmH rpmI rpmJ rpmJ2 rpsA rpsB rpsC rpsD rpsE rpsF rpsG rpsH rpsI rpsJ rpsK rpsL rpsM rpsN rpsO rpsP rpsQ rpsR rpsR1 rpsR2 rpsS rpsT rpsU rpsZ ykgM ykgO

The experimentally established mechanism targets of Sulfuric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

	gene	UniProt	supporting neighbours	confidence
▸	CA5A	P35218	2/20	0.60

▸	CA5B	Q9Y2D0	2/20	0.60

▸	TSHR	P16473	3/20	0.39

▸	CA2	P00918	2/20	0.39

▸	CA1	P00915	1/20	0.39

▸	NT5E	P21589	1/20	0.39

▸	CA4	P22748	1/20	0.39

▸	CA6	P23280	1/20	0.39

▸	CA7	P43166	1/20	0.39

▸	CA9	Q16790	1/20	0.39

▸	TDP1	Q9NUW8	1/20	0.39

▸	BLM	P54132	2/20	0.38

▸	KDM4E	B2RXH2	2/20	0.38

▸	MEN1	O00255	1/20	0.36

▸	ALDH1A1	P00352	1/20	0.36

▸	KMT2A	Q03164	1/20	0.36

▸	PTGS1	P23219	1/20	0.33

▸	PDE4A	P27815	1/20	0.33

▸	CYP2D6	P10635	1/20	0.30

▸	CYP2C19	P33261	1/20	0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compound	similarity	top predicted	shared targets
Sulfuric Acid SCHEMBL28131771	1.00	CA5A (0.60)	CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL3958702	0.95	CA5A (0.55)	CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL28235028	0.95	CA5A (0.55)	CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL28725360	0.95	CA5A (0.55)	CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL9767658	0.95	CA5A (0.55)	CA5ACA5BTSHRCA2CA1
Thiosulfuric Acid SCHEMBL8512498	0.95	CA5A (0.50)	CA5ACA5BTSHRCA2CA1
Thiosulfuric Acid SCHEMBL16761679	0.95	—	—
Thiosulfuric Acid SCHEMBL11785568	0.95	CA5A (0.50)	CA5ACA5BTSHRCA2CA1
Thiosulfuric Acid SCHEMBL3422841	0.95	CA5A (0.50)	CA5ACA5BTSHRCA2CA1
Sulfuric Acid SCHEMBL7108516	0.95	CA5A (0.67)	CA5ACA5BTSHRCA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

Patent	Title	Assignee	Published	Priority	Filing	Country	Status
CN-119998400-A	Polycarbonate compositions, methods for preparing the same, and articles comprising the polycarbonate compositions	高新特殊工程塑料全球技术有限公司	2025-05-13	—	—	CN	disclosed
CN-119278237-A	Anti-drip polycarbonate compositions	高新特殊工程塑料全球技术有限公司	2025-01-07	—	—	CN	disclosed
CN-118984851-A	PBT-alumina composite particles, methods, and molded parts	高新特殊工程塑料全球技术有限公司	2024-11-19	—	—	CN	disclosed
CN-118632900-A	Thermoplastic composition	高新特殊工程塑料全球技术有限公司	2024-09-10	—	—	CN	disclosed
CN-116041597-B	Polybutadiene latex and ABS resin and preparation method thereof	金发科技股份有限公司	2024-08-13	—	—	CN	disclosed
CN-116848192-A	Thermoplastic composition	高新特殊工程塑料全球技术有限公司	2023-10-03	—	—	CN	disclosed
CN-116041597-A	Polybutadiene latex and ABS resin and preparation method thereof	金发科技股份有限公司	2023-05-02	—	—	CN	disclosed
US-20150315188-A1	COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION	MEDIVATION TECHNOLOGIES, INC.	2015-11-05	—	—	US	disclosed
EP-2887805-A1	COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION	Medivation Technologies, Inc. (US)	2015-07-01	—	—	EP	disclosed
WO-2014031165-A1	COMPOUNDS AND METHODS OF TREATING DIABETES	MEDIVATION TECHNOLOGIES, INC. (US)	2014-02-27	—	—	WO	disclosed
WO-2014031167-A1	COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION	MEDIVATION TECHNOLOGIES, INC. (US)	2014-02-27	—	—	WO	disclosed
WO-2014031170-A1	PYRIDO[4,3-B]INDOLE AND PYRIDO[3,4-B]INDOLE DERIVATIVES AND METHODS OF USE	MEDIVATION TECHNOLOGIES, INC. (US)	2014-02-27	—	—	WO	disclosed
EP-1608622-A4	BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS	MERCK & CO INC (US)	2009-04-01	—	—	EP	disclosed
US-20060293339-A1	Biaryl substituted 6-membered heterocycles as sodium channel blockers	MERCK SHARP & DOHME CORP.	2006-12-28	—	—	US	disclosed
EP-1608622-A2	BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS	Merck & Co., Inc. (US)	2005-12-28	—	—	EP	disclosed
CN-1709349-A	Corydalis amabilis injection agent, and its preparation and quality control method	WANG HENGXIN (CN)	2005-12-21	—	—	CN	disclosed
WO-2004084824-A2	BIARYL SUBSTITUTED 6-MEMBERED HETEROCYLES AS SODIUM CHANNEL BLOCKERS	MERCK & CO., INC. (US)	2004-10-07	—	—	WO	disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

Patent	Title	Text reads most about	Predicted target · text-rank
US-20150315188-A1	COMPOUNDS AND METHODS FOR TREATMENT OF HYPERTENSION	ADRB2, ADRA2B, ADRB1	CA5A 996/4885CA5B 380/4885TSHR 282/4885
US-20060293339-A1	Biaryl substituted 6-membered heterocycles as sodium channel blockers	TRPV1, SCN2A, SCN2B	CA5A 977/4885CA5B 695/4885TSHR 1527/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.